This webinar will present the business opportunity of delivering high quality SEND datasets guaranteed to pass through the NIMS gateway at the FDA while bringing improved efficiency to sponsor-CRO data specifications. We will discuss how this can be done with minimal disruption to your existing business processes.
On December 17, 2014 the FDA issued a binding guidance requiring SEND compliance. In the future, few sponsors, if any, will deal with CROs that cannot provide a valid SEND dataset for the studies they conduct. CROs should embrace SEND as an opportunity to gain a competitive edge and enhance their revenues.
For more information, please contact: